Makale
Tam Makale
Uluslararası
2003
The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis
PANMINERVA MEDICA
Cilt 45 · Sayı 1 · ss. 59–62 · 01.03.2003
Özet
Aim. In some of the patients undergoing haemodialysis, (HD) resistance might develop against recombinant human erythropoietin (rHuEPO) used for treatment of anaemia. Recently, angiotensin-converting enzyme (ACE) inhibitors that are used to treat hypertension and congestive heart failure in HD patients have been suggested to contribute to anaemia as well by inhibiting erythropoiesis. Our purpose in this study is to investigate whether or not losartan, an angiotensin II (ATII) receptor antagonist, is causing rHuEPO resistance.
Anahtar kelimeler
chronic renal failure
VOLUNTEERS
C-REACTIVE PROTEIN
ANEMIA
erythropoietin
CONVERTING ENZYME-INHIBITORS
REQUIREMENTS
Dialysis
anaemia
renal dialysis
angiotensin converting enzyme inhibitors
POSTTRANSPLANT ERYTHROCYTOSIS
HEMODIALYSIS-PATIENTS
ENALAPRIL
Atıf için künye
ODABAŞ, A. R., ÇETİNKAYA, R., SELÇUK, N. Y., KELEŞ, S., & Bilen, H. (2003). The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis. PANMINERVA MEDICA, 45(1), 59–62.
BibTeX
@article{odabas2003-228706,
author = {ODABAŞ, ALİ RIZA and ÇETİNKAYA, RAMAZAN and SELÇUK, NEDİM YILMAZ and KELEŞ, S and Bilen, Habib},
title = {The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis},
journal = {PANMINERVA MEDICA},
year = {2003},
volume = {45},
number = {1},
pages = {59--62},
issn = {0031-0808},
url = {https://akademik.atauni.edu.tr/yayinlar/228706-the-effect-of-high-dose-losartan-on-erythropoietin-resistance-in-patients}
}